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Bronchoalveolar lavage ﬂuid (BALF) in patients with idiopathic pulmonary ﬁbrosis (IPF) is typically
characterized by a neutrophil inﬂammatory pattern and to a lesser extent (<25%) a mild eosinophil
alveolitis. We here present two patients with a deﬁnite usual interstitial pneumonia (UIP) pattern on
high-resolution computed tomography of the thorax (HRCT) which demonstrated unusually high
eosinophil counts in the BALF (40% and 51%). Based on HRCT, lack of response to steroids and the disease
course they were both diagnosed as IPF after a multidisciplinary team discussion. This report discusses
the diagnostic and etiological considerations of a coexisting UIP pattern and an eosinophil alveolitis. We
conclude that these cases illustrate that high level BALF eosinophilia (40e50%) may occur among pa-
tients with IPF.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Idiopathic pulmonary ﬁbrosis (IPF) is a rare, progressive ﬁbrotic
lung disease of unknown cause with a dismal outcome. IPF is
limited to the lungs and associated with the radiologic and/or
histopathologic pattern of usual interstitial pneumonia (UIP) [1].
Bronchoalveolar lavage ﬂuid (BALF) in patients with idiopathic
pulmonary ﬁbrosis (IPF) is typically characterized by a neutrophil
inﬂammatory pattern and to a lesser extent (<25%) a mild eosin-
ophil alveolitis [2,3].
Only 50% of patients with IPF have a deﬁnite UIP pattern on
high-resolution computed tomography of the thorax (HRCT). A
surgical lung biopsy is often considered too risky in many patients
[4e6]. According to the recent guidelines on IPF [3], bronchoalvelar
lavage (BAL) should not be performed in the diagnostic evaluation
in the majority of patients, but may be appropriate in a minority.
However, this is a weak recommendation with low-quality evi-
dence focusing solely on patients with a deﬁnite UIP pattern. Pa-
tients with a possible UIP pattern on HRCT represent a grey zone
group and BAL may be diagnostically helpful in this setting. Many
centers including our center do BAL in patients with both a possible
and a deﬁnite UIP pattern on HRCT as part of the standard.
Ltd. This is an open access article udiagnostic work up.
A previous study reported of six patients with a deﬁnite radio-
logic and histopathologic pattern of UIP and with coexistent
eosinophilic pneumonia in surgical lung biopsies [7].
We here present two patients with a high level BALF eosino-
philia (40e50%) and a deﬁnite UIP pattern on HRCT. We further
discuss combination of an eosinophil alveolitis and a UIP pattern.
No previous studies have reported this high eosinophil count in
patients with IPF.
1.1. Case 1
A 63-year-old man was referred due to progressive dyspnea
when walking on stairs (Medical Research Council Dyspnea Scale
(MRC) grade 2) during two months and a cough with clear sputum.
He was a smoker (40 pack years) but previously healthy. He had no
environmental or occupational exposures, no history of a recent
infection, no history of drugs with pulmonary toxicity, no autoim-
mune disorder or family history.
1.2. Case 2
A 64-year-old man, with randomly discovered radiological signs
of interstitial lung disease prior to methotrexate treatment for se-
vere psoriasis, was referred for assessment. Because of the ﬁndings,
methotrexate was not initiated. He had had dyspnea whenwalkingnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Image 2. High-resolution computed tomography of the thorax in sagittal plane of case
2. It shows honeycombing, traction bronchiectasis and reticulation with basal pre-
dominance, consistent with deﬁnite UIP pattern.
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sputum. He had stopped smoking 15 years ago but had cumulated
30 pack years. He had no history of recent infection, no history of




Blood samples, including peripheral blood eosinophils (EOS),
antinuclear antibodies (ANA), anti-neutrophil cytoplasmic anti-
bodies (ANCA), and rheumatoid factor (IgM-RF), were normal. The
patients had no signs of infection and no recent traveling. The
physical examination was normal without clubbing. Six minute
walk test distance was 612 m, with desaturation from 99% to 92%.
The pulmonary function test (PFT) showed FEV1 2.72 (75%), FVC
4.19 (90%), FEV1/FVC 83%. DLCO 47% and TLC 79%. HRCT (Image 1)
showed a deﬁnite UIP pattern with basal predominance of honey-
combing, reticulation and traction bronchiectasis. BALF cell count
showed 40% eosinophils, 51% macrophages and 9% neutrophils.
Treatment with high-dose prednisolone was initiated with a
gradual taper after 4 months. PFT did not improve on prednisolone
treatment. In a multidisciplinary team discussion, the patient was
diagnosed with IPF based on age, smoking history, deﬁnite UIP
pattern on HRCT and non-responsiveness to steroids. Pirfenidone
was initiated. Lung function and symptoms has been stable since.
2.2. Case 2
Blood samples, including EOS, ANA, ANCA and IgM-RF, were
normal. The patients had no signs of infection and no recent trav-
eling. The physical examination was normal. Six minute walk test
distancewas 500mwith desaturation from 97% to 91%. PFT showed
a FEV1 2.82 L (90%), FVC 3.77 (94%), ratio of 96%, DLCO 49% and TLC
73%. HRCT (Image 2) showed deﬁnite UIP pattern with honey-
combing, traction bronchiectasis and reticulation with basal pre-
dominance. BALF cell count showed 51% eosinophils, 48%
macrophages and 2% mast cells. Treatment with high-dose pred-
nisolone was initiated, but PFT did not improve. In a multidisci-
plinary team discussion, the patient was diagnosed with IPF based
on age, smoking history, deﬁnite UIP pattern on HRCT and non-
responsiveness to steroids. Subsequently, the patient was recom-
mended anti-ﬁbrotic therapy to prevent progression, but rejectedImage 1. High-resolution computed tomography (HRCT) of the thorax in coronal plane
of case 1. It shows honeycombing, traction bronchiectasis and reticulation with basal
predominance, consistent with deﬁnite usual interstitial pneumonia (UIP) pattern.it. Lung function and symptoms has been stable for 14 months.3. Discussion
3.1. Guidelines for diagnosis of IPF: BAL or not?
In the appropriate clinical setting, the presence of a UIP pattern
on HRCT is sufﬁcient for the diagnosis of IPF, given the high-quality
evidence regarding HRCT speciﬁcity for the recognition of histo-
pathologic UIP pattern [4,8e10]. Several studies have documented
that UIP pattern on HRCT is highly accurate for the presence of UIP
pattern on a surgical lung biopsy [3,8,11,12]. A surgical biopsy was
not performed in the cases presented, as both had deﬁnite UIP
pattern on HRCT and no obvious exposures. In retrospect a biopsy
would have been academically interesting, but without conse-
quences for diagnosis or treatment. However, it would have been of
interest to see whether a biopsy had revealed coexistent eosino-
philic pneumonia, as found by Yousem et al. [7], especially as BAL
not were performed in his cases.
The clinical utility of BAL cell analysis for the diagnosis and
management of patients with ILD has been a subject of debate and
controversy. The recommendations concerning the use of BAL in
patients with ILD were reversed in 2012, based on an expert group
assessment of the relevant literature [13]. Though, when used in
conjunction with comprehensive clinical information and HRCT
scan, BAL cell patterns and other characteristics frequently provide
useful information for the diagnostic evaluation of patients with
suspected ILD [4]. Recent retrospective data suggest that 8% of
patients with an HRCT UIP pattern may have BAL ﬁndings sugges-
tive of an alternative diagnosis. It is unclear whether BAL adds
signiﬁcant diagnostic speciﬁcity to a careful exposure history and
clinical evaluation [14].3.2. The importance of eosinophilia
Eosinophils are relatively rare in the normal lung and so they
stand out both in tissue and airway lumen samples when present in
increased numbers. Eosinophils have been proven to be cytotoxic
and pro-inﬂammatory effector cells in non-infectious disorders
where they are prominent, though the extent to which eosinophils
cause tissue damage remains controversial [15e21].
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of eosinophils >3% in BALF of patients with UIP are associated with
a poor response to steroids, more severe functional abnormalities,
and a worse prognosis [22e25]. Yousem et al. suggested that
eosinophilic pneumonia may be one histologic correlate of these
zones of activity [12]. Previous studies of UIP cases report
maximum 25% eosinophils in BALF. Modest increases in BAL eo-
sinophils (<25%) have been found in up to 45% of the cases
[23,25e27]. Histologic correlations with BAL studies fail to show
associations of BALF eosinophilia and speciﬁc morphologic patterns
of injury [25,28,29].
3.3. Coexisting eosinophilic pneumonia and UIP in previous study
Yousem et al. report six patients with idiopathic UIP who had
patchy areas of eosinophilic pneumonia superimposed on the un-
derlying UIP pattern. Five of the six patients were men and
smokers. The average age was 49 years (range: 38e58 years) and
neither had a history of peripheral blood eosinophilia. Unfortu-
nately, none of the six patients had BAL performed before biopsy.
The study suggested that the interstitial and air space damage
associated with air space eosinophils may represent an atypical
form of active interstitial injury [7]. Four of the patients had high-
dose steroids, two combined with cyclophosphamide and one
with methotrexate. One remained alive with evidence of disease
and three died of their disease after respectively 4, 13 and 18
months. Two patients had single lung transplantation.
3.4. Differential diagnosis
Eosinophil alveolitis in the setting of a radiologic UIP pattern
raises several differential diagnostic possibilities. A markedly
increased eosinophil count (25%) in BAL is typically a manifesta-
tion of idiopathic acute eosinophilic pneumonia (AEP), chronic
eosinophilic pneumonia (CEP), Churg Strauss syndromewith active
pneumonitis, tropical pulmonary eosinophilia or the hyper-
eosinophilic syndrome (HES). These diseases are characterized by
an increased number of eosinophils in peripheral blood, in lung
tissue, in sputum, in BALF, or in all of these [6,26,30].
Cigarette smoking has been associated with increased BALF
eosinophils in the setting of UIP, but masses of air space eosinophils
are not seen in smokers' bronchiolitis. There is a strong association
between tobacco smoking and AEP. A study from 2014 [31] showed
that smoking increases the BAL levels of IL-5 and IL-1RA and eo-
sinophils which is associated with the onset of AEP. Typically, BAL
eosinophils are less than 5% in smokers [32,33]. Smoking is also
considered as a possible agent in the pathogenesis of IPF [2,13].
4. Conclusion
In summary, this report describes two patients with a radiologic
deﬁnite UIP pattern with coexistent eosinophil alveolitis. Based on
HRCT, lack of treatment response and a disease course compatible
with IPF, both patients were classiﬁed as IPF after a multidisci-
plinary team discussion. Thus, a high level BALF eosinophilia
(40e50%) may occur among patients with IPF.
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